Pediatrix Medical Group, Inc. (NYSE: MD) Stock Competitors & Peer Comparison
See MD's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MD and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MD | $27.38 | -1.37% | 2.2B | 12.21 | $2.24 | N/A |
| HCA | $458.84 | -2.06% | 99.3B | 15.84 | $28.96 | +0.67% |
| THC | $267.25 | -2.86% | 21.5B | 15.50 | $17.24 | N/A |
| EHC | $127.87 | +0.08% | 12.6B | 21.90 | $5.84 | +0.61% |
| DVA | $187.31 | -0.98% | 11.9B | 14.62 | $12.80 | N/A |
| FMS | $22.17 | +0.18% | 11.8B | 8.33 | $2.66 | +3.90% |
| UHS | $185.10 | -1.21% | 10.9B | 8.21 | $22.54 | +0.43% |
| ENSG | $176.63 | -0.83% | 10.3B | 25.60 | $6.90 | +0.15% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| PACS | $46.91 | -1.76% | 7.4B | 24.83 | $1.89 | N/A |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
MD vs HCA Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, HCA has a market cap of 99.3B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while HCA trades at $458.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas HCA's P/E ratio is 15.84. In terms of profitability, MD's ROE is +0.20%, compared to HCA's ROE of -1.13%. Regarding short-term risk, MD is less volatile compared to HCA. This indicates lower risk in terms of short-term price fluctuations for MD.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
MD vs THC Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, THC has a market cap of 21.5B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while THC trades at $267.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas THC's P/E ratio is 15.50. In terms of profitability, MD's ROE is +0.20%, compared to THC's ROE of +0.51%. Regarding short-term risk, MD is less volatile compared to THC. This indicates lower risk in terms of short-term price fluctuations for MD.Check THC's competition here
Encompass Health Corporation (NYSE: EHC)
MD vs EHC Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, EHC has a market cap of 12.6B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while EHC trades at $127.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas EHC's P/E ratio is 21.90. In terms of profitability, MD's ROE is +0.20%, compared to EHC's ROE of +0.25%. Regarding short-term risk, MD is more volatile compared to EHC. This indicates higher risk in terms of short-term price fluctuations for MD.Check EHC's competition here
DaVita Inc. (NYSE: DVA)
MD vs DVA Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, DVA has a market cap of 11.9B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while DVA trades at $187.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas DVA's P/E ratio is 14.62. In terms of profitability, MD's ROE is +0.20%, compared to DVA's ROE of -1.24%. Regarding short-term risk, MD is more volatile compared to DVA. This indicates higher risk in terms of short-term price fluctuations for MD.Check DVA's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
MD vs FMS Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, FMS has a market cap of 11.8B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while FMS trades at $22.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas FMS's P/E ratio is 8.33. In terms of profitability, MD's ROE is +0.20%, compared to FMS's ROE of +0.07%. Regarding short-term risk, MD is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for MD.Check FMS's competition here
Universal Health Services, Inc. (NYSE: UHS)
MD vs UHS Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, UHS has a market cap of 10.9B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while UHS trades at $185.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas UHS's P/E ratio is 8.21. In terms of profitability, MD's ROE is +0.20%, compared to UHS's ROE of +0.21%. Regarding short-term risk, MD is less volatile compared to UHS. This indicates lower risk in terms of short-term price fluctuations for MD.Check UHS's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
MD vs ENSG Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, ENSG has a market cap of 10.3B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while ENSG trades at $176.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas ENSG's P/E ratio is 25.60. In terms of profitability, MD's ROE is +0.20%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, MD is more volatile compared to ENSG. This indicates higher risk in terms of short-term price fluctuations for MD.Check ENSG's competition here
Oak Street Health, Inc. (NYSE: OSH)
MD vs OSH Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas OSH's P/E ratio is -17.65. In terms of profitability, MD's ROE is +0.20%, compared to OSH's ROE of +4.64%. Regarding short-term risk, MD is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for MD.Check OSH's competition here
PACS Group, Inc. (NYSE: PACS)
MD vs PACS Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, PACS has a market cap of 7.4B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while PACS trades at $46.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas PACS's P/E ratio is 24.83. In terms of profitability, MD's ROE is +0.20%, compared to PACS's ROE of +0.27%. Regarding short-term risk, MD is less volatile compared to PACS. This indicates lower risk in terms of short-term price fluctuations for MD.Check PACS's competition here
Chemed Corporation (NYSE: CHE)
MD vs CHE Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, CHE has a market cap of 6.7B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while CHE trades at $512.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas CHE's P/E ratio is 23.70. In terms of profitability, MD's ROE is +0.20%, compared to CHE's ROE of +0.29%. Regarding short-term risk, MD is more volatile compared to CHE. This indicates higher risk in terms of short-term price fluctuations for MD.Check CHE's competition here
Hims & Hers Health, Inc. (NYSE: HIMS)
MD vs HIMS Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, HIMS has a market cap of 6.3B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while HIMS trades at $28.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas HIMS's P/E ratio is -43.82. In terms of profitability, MD's ROE is +0.20%, compared to HIMS's ROE of -0.30%. Regarding short-term risk, MD is less volatile compared to HIMS. This indicates lower risk in terms of short-term price fluctuations for MD.Check HIMS's competition here
LHC Group, Inc. (NASDAQ: LHCG)
MD vs LHCG Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas LHCG's P/E ratio is 82.83. In terms of profitability, MD's ROE is +0.20%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, MD is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for MD.Check LHCG's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
MD vs CON Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, CON has a market cap of 4.9B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while CON trades at $38.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas CON's P/E ratio is 24.24. In terms of profitability, MD's ROE is +0.20%, compared to CON's ROE of +0.47%. Regarding short-term risk, MD is more volatile compared to CON. This indicates higher risk in terms of short-term price fluctuations for MD.Check CON's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
MD vs OPCH Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, OPCH has a market cap of 4.7B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while OPCH trades at $31.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas OPCH's P/E ratio is 18.14. In terms of profitability, MD's ROE is +0.20%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, MD is more volatile compared to OPCH. This indicates higher risk in terms of short-term price fluctuations for MD.Check OPCH's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
MD vs LFST Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, LFST has a market cap of 4.5B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while LFST trades at $11.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas LFST's P/E ratio is 88.35. In terms of profitability, MD's ROE is +0.20%, compared to LFST's ROE of +0.03%. Regarding short-term risk, MD is less volatile compared to LFST. This indicates lower risk in terms of short-term price fluctuations for MD.Check LFST's competition here
National HealthCare Corporation (AMEX: NHC)
MD vs NHC Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, NHC has a market cap of 3.8B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while NHC trades at $242.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas NHC's P/E ratio is 31.02. In terms of profitability, MD's ROE is +0.20%, compared to NHC's ROE of +0.13%. Regarding short-term risk, MD is more volatile compared to NHC. This indicates higher risk in terms of short-term price fluctuations for MD.Check NHC's competition here
Amedisys, Inc. (NASDAQ: AMED)
MD vs AMED Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas AMED's P/E ratio is 39.30. In terms of profitability, MD's ROE is +0.20%, compared to AMED's ROE of +0.04%. Regarding short-term risk, MD is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for MD.Check AMED's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
MD vs ACHC Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, ACHC has a market cap of 2.8B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while ACHC trades at $29.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas ACHC's P/E ratio is 15.07. In terms of profitability, MD's ROE is +0.20%, compared to ACHC's ROE of -0.50%. Regarding short-term risk, MD is less volatile compared to ACHC. This indicates lower risk in terms of short-term price fluctuations for MD.Check ACHC's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
MD vs AVAH Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, AVAH has a market cap of 2.7B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while AVAH trades at $12.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas AVAH's P/E ratio is 18.15. In terms of profitability, MD's ROE is +0.20%, compared to AVAH's ROE of +1.50%. Regarding short-term risk, MD is less volatile compared to AVAH. This indicates lower risk in terms of short-term price fluctuations for MD.Check AVAH's competition here
Guardian Pharmacy Services, Inc. (NYSE: GRDN)
MD vs GRDN Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, GRDN has a market cap of 2.5B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while GRDN trades at $39.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas GRDN's P/E ratio is 34.65. In terms of profitability, MD's ROE is +0.20%, compared to GRDN's ROE of +0.31%. Regarding short-term risk, MD is more volatile compared to GRDN. This indicates higher risk in terms of short-term price fluctuations for MD.Check GRDN's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
MD vs BKD Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, BKD has a market cap of 2.4B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while BKD trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas BKD's P/E ratio is -17.38. In terms of profitability, MD's ROE is +0.20%, compared to BKD's ROE of +4.06%. Regarding short-term risk, MD is more volatile compared to BKD. This indicates higher risk in terms of short-term price fluctuations for MD.Check BKD's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
MD vs ADUS Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, ADUS has a market cap of 2.2B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while ADUS trades at $115.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas ADUS's P/E ratio is 17.36. In terms of profitability, MD's ROE is +0.20%, compared to ADUS's ROE of +0.10%. Regarding short-term risk, MD is more volatile compared to ADUS. This indicates higher risk in terms of short-term price fluctuations for MD.Check ADUS's competition here
Select Medical Holdings Corporation (NYSE: SEM)
MD vs SEM Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, SEM has a market cap of 2B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas SEM's P/E ratio is 15.43. In terms of profitability, MD's ROE is +0.20%, compared to SEM's ROE of +0.08%. Regarding short-term risk, MD is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for MD.Check SEM's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
MD vs SGRY Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, SGRY has a market cap of 1.9B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while SGRY trades at $14.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas SGRY's P/E ratio is 37.46. In terms of profitability, MD's ROE is +0.20%, compared to SGRY's ROE of -0.05%. Regarding short-term risk, MD is more volatile compared to SGRY. This indicates higher risk in terms of short-term price fluctuations for MD.Check SGRY's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
MD vs AMEH Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas AMEH's P/E ratio is 39.25. In terms of profitability, MD's ROE is +0.20%, compared to AMEH's ROE of +0.05%. Regarding short-term risk, MD is less volatile compared to AMEH. This indicates lower risk in terms of short-term price fluctuations for MD.Check AMEH's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
MD vs ASTH Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, ASTH has a market cap of 1.8B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while ASTH trades at $36.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas ASTH's P/E ratio is 44.30. In terms of profitability, MD's ROE is +0.20%, compared to ASTH's ROE of +0.05%. Regarding short-term risk, MD is less volatile compared to ASTH. This indicates lower risk in terms of short-term price fluctuations for MD.Check ASTH's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
MD vs SNDA Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, SNDA has a market cap of 1.7B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while SNDA trades at $35.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas SNDA's P/E ratio is -5.70. In terms of profitability, MD's ROE is +0.20%, compared to SNDA's ROE of -0.26%. Regarding short-term risk, MD is more volatile compared to SNDA. This indicates higher risk in terms of short-term price fluctuations for MD.Check SNDA's competition here
Ardent Health Inc. (NYSE: ARDT)
MD vs ARDT Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, ARDT has a market cap of 1.7B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while ARDT trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas ARDT's P/E ratio is 9.65. In terms of profitability, MD's ROE is +0.20%, compared to ARDT's ROE of +0.05%. Regarding short-term risk, MD is less volatile compared to ARDT. This indicates lower risk in terms of short-term price fluctuations for MD.Check ARDT's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
MD vs AMN Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, AMN has a market cap of 1.6B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while AMN trades at $40.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas AMN's P/E ratio is 13.45. In terms of profitability, MD's ROE is +0.20%, compared to AMN's ROE of +0.15%. Regarding short-term risk, MD is less volatile compared to AMN. This indicates lower risk in terms of short-term price fluctuations for MD.Check AMN's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
MD vs PNTG Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, PNTG has a market cap of 1.5B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while PNTG trades at $41.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas PNTG's P/E ratio is 31.72. In terms of profitability, MD's ROE is +0.20%, compared to PNTG's ROE of +0.10%. Regarding short-term risk, MD is more volatile compared to PNTG. This indicates higher risk in terms of short-term price fluctuations for MD.Check PNTG's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
MD vs HCSG Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, HCSG has a market cap of 1.5B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while HCSG trades at $21.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas HCSG's P/E ratio is 16.90. In terms of profitability, MD's ROE is +0.20%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, MD is more volatile compared to HCSG. This indicates higher risk in terms of short-term price fluctuations for MD.Check HCSG's competition here
Agilon Health, Inc. (NYSE: AGL)
MD vs AGL Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, AGL has a market cap of 1.4B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while AGL trades at $85.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas AGL's P/E ratio is -5.53. In terms of profitability, MD's ROE is +0.20%, compared to AGL's ROE of -1.19%. Regarding short-term risk, MD is less volatile compared to AGL. This indicates lower risk in terms of short-term price fluctuations for MD.Check AGL's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
MD vs USPH Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, USPH has a market cap of 1.3B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while USPH trades at $85.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas USPH's P/E ratio is 33.78. In terms of profitability, MD's ROE is +0.20%, compared to USPH's ROE of -0.01%. Regarding short-term risk, MD is more volatile compared to USPH. This indicates higher risk in terms of short-term price fluctuations for MD.Check USPH's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
MD vs NUTX Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, NUTX has a market cap of 1.3B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while NUTX trades at $186.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas NUTX's P/E ratio is 7.36. In terms of profitability, MD's ROE is +0.20%, compared to NUTX's ROE of +0.52%. Regarding short-term risk, MD is less volatile compared to NUTX. This indicates lower risk in terms of short-term price fluctuations for MD.Check NUTX's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
MD vs BKDT Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas BKDT's P/E ratio is N/A. In terms of profitability, MD's ROE is +0.20%, compared to BKDT's ROE of +4.06%. Regarding short-term risk, MD is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for MD.Check BKDT's competition here
Innovage Holding Corp. (NASDAQ: INNV)
MD vs INNV Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, INNV has a market cap of 1.2B. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while INNV trades at $8.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas INNV's P/E ratio is -442.50. In terms of profitability, MD's ROE is +0.20%, compared to INNV's ROE of -0.01%. Regarding short-term risk, MD is less volatile compared to INNV. This indicates lower risk in terms of short-term price fluctuations for MD.Check INNV's competition here
Talkspace, Inc. (NASDAQ: TALK)
MD vs TALK Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, TALK has a market cap of 870.6M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while TALK trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas TALK's P/E ratio is 774.34. In terms of profitability, MD's ROE is +0.20%, compared to TALK's ROE of +0.00%. Regarding short-term risk, MD is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for MD.Check TALK's competition here
Enhabit, Inc. (NYSE: EHAB)
MD vs EHAB Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas EHAB's P/E ratio is -197.14. In terms of profitability, MD's ROE is +0.20%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, MD is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for MD.Check EHAB's competition here
Starling Oncology, Inc. (NASDAQ: STLN)
MD vs STLN Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, STLN has a market cap of 642.9M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while STLN trades at $6.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas STLN's P/E ratio is -21.07. In terms of profitability, MD's ROE is +0.20%, compared to STLN's ROE of +2.10%. Regarding short-term risk, MD is less volatile compared to STLN. This indicates lower risk in terms of short-term price fluctuations for MD.Check STLN's competition here
GMR Solutions Inc. (NYSE: GMRS)
MD vs GMRS Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, GMRS has a market cap of 540.5M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while GMRS trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas GMRS's P/E ratio is -4.93. In terms of profitability, MD's ROE is +0.20%, compared to GMRS's ROE of +0.16%. Regarding short-term risk, MD is less volatile compared to GMRS. This indicates lower risk in terms of short-term price fluctuations for MD.Check GMRS's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
MD vs TOI Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, TOI has a market cap of 512.9M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while TOI trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas TOI's P/E ratio is -14.25. In terms of profitability, MD's ROE is +0.20%, compared to TOI's ROE of +2.10%. Regarding short-term risk, MD is less volatile compared to TOI. This indicates lower risk in terms of short-term price fluctuations for MD.Check TOI's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
MD vs MCTA Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas MCTA's P/E ratio is 419.36. In terms of profitability, MD's ROE is +0.20%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, MD is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for MD.Check MCTA's competition here
Community Health Systems, Inc. (NYSE: CYH)
MD vs CYH Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, CYH has a market cap of 406.8M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while CYH trades at $2.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas CYH's P/E ratio is 3.95. In terms of profitability, MD's ROE is +0.20%, compared to CYH's ROE of +0.21%. Regarding short-term risk, MD is less volatile compared to CYH. This indicates lower risk in terms of short-term price fluctuations for MD.Check CYH's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
MD vs SRTA Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, SRTA has a market cap of 401.6M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while SRTA trades at $4.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas SRTA's P/E ratio is -21.40. In terms of profitability, MD's ROE is +0.20%, compared to SRTA's ROE of +0.14%. Regarding short-term risk, MD is less volatile compared to SRTA. This indicates lower risk in terms of short-term price fluctuations for MD.Check SRTA's competition here
Auna S.A. (NYSE: AUNA)
MD vs AUNA Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, AUNA has a market cap of 394.1M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while AUNA trades at $5.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas AUNA's P/E ratio is 4.80. In terms of profitability, MD's ROE is +0.20%, compared to AUNA's ROE of +0.01%. Regarding short-term risk, MD is more volatile compared to AUNA. This indicates higher risk in terms of short-term price fluctuations for MD.Check AUNA's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
MD vs VMD Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, VMD has a market cap of 361.1M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while VMD trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas VMD's P/E ratio is 26.33. In terms of profitability, MD's ROE is +0.20%, compared to VMD's ROE of +0.10%. Regarding short-term risk, MD is less volatile compared to VMD. This indicates lower risk in terms of short-term price fluctuations for MD.Check VMD's competition here
Capital Senior Living Corporation (NYSE: CSU)
MD vs CSU Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas CSU's P/E ratio is 0.67. In terms of profitability, MD's ROE is +0.20%, compared to CSU's ROE of -0.33%. Regarding short-term risk, MD is less volatile compared to CSU. This indicates lower risk in terms of short-term price fluctuations for MD.Check CSU's competition here
The Joint Corp. (NASDAQ: JYNT)
MD vs JYNT Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, JYNT has a market cap of 100.3M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while JYNT trades at $7.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas JYNT's P/E ratio is 47.27. In terms of profitability, MD's ROE is +0.20%, compared to JYNT's ROE of +0.22%. Regarding short-term risk, MD is less volatile compared to JYNT. This indicates lower risk in terms of short-term price fluctuations for MD.Check JYNT's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
MD vs FVE Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas FVE's P/E ratio is -5.64. In terms of profitability, MD's ROE is +0.20%, compared to FVE's ROE of -0.15%. Regarding short-term risk, MD is more volatile compared to FVE. This indicates higher risk in terms of short-term price fluctuations for MD.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
MD vs KDLYW Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas KDLYW's P/E ratio is N/A. In terms of profitability, MD's ROE is +0.20%, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, MD is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for MD.Check KDLYW's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
MD vs AIRS Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, AIRS has a market cap of 91.9M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while AIRS trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas AIRS's P/E ratio is -42.50. In terms of profitability, MD's ROE is +0.20%, compared to AIRS's ROE of -0.13%. Regarding short-term risk, MD is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for MD.Check AIRS's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
MD vs PARK Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, PARK has a market cap of 90.1M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while PARK trades at $18.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas PARK's P/E ratio is 25.61. In terms of profitability, MD's ROE is +0.20%, compared to PARK's ROE of -0.18%. Regarding short-term risk, MD is more volatile compared to PARK. This indicates higher risk in terms of short-term price fluctuations for MD.Check PARK's competition here
biote Corp. (NASDAQ: BTMD)
MD vs BTMD Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, BTMD has a market cap of 47.9M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while BTMD trades at $1.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas BTMD's P/E ratio is 9.86. In terms of profitability, MD's ROE is +0.20%, compared to BTMD's ROE of -0.09%. Regarding short-term risk, MD is less volatile compared to BTMD. This indicates lower risk in terms of short-term price fluctuations for MD.Check BTMD's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
MD vs EUDA Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, EUDA has a market cap of 45.9M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while EUDA trades at $15.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas EUDA's P/E ratio is -13.18. In terms of profitability, MD's ROE is +0.20%, compared to EUDA's ROE of -5.06%. Regarding short-term risk, MD is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for MD.Check EUDA's competition here
AlerisLife Inc. (NASDAQ: ALR)
MD vs ALR Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas ALR's P/E ratio is -1.11. In terms of profitability, MD's ROE is +0.20%, compared to ALR's ROE of -0.15%. Regarding short-term risk, MD is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for MD.Check ALR's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
MD vs CCEL Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, CCEL has a market cap of 35.5M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while CCEL trades at $4.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas CCEL's P/E ratio is -19.13. In terms of profitability, MD's ROE is +0.20%, compared to CCEL's ROE of +0.16%. Regarding short-term risk, MD is less volatile compared to CCEL. This indicates lower risk in terms of short-term price fluctuations for MD.Check CCEL's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
MD vs IMAC Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas IMAC's P/E ratio is -2.27. In terms of profitability, MD's ROE is +0.20%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, MD is more volatile compared to IMAC. This indicates higher risk in terms of short-term price fluctuations for MD.Check IMAC's competition here
DocGo Inc. (NASDAQ: DCGO)
MD vs DCGO Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, DCGO has a market cap of 26.9M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while DCGO trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas DCGO's P/E ratio is -0.15. In terms of profitability, MD's ROE is +0.20%, compared to DCGO's ROE of -1.16%. Regarding short-term risk, MD is less volatile compared to DCGO. This indicates lower risk in terms of short-term price fluctuations for MD.Check DCGO's competition here
Cano Health, Inc. (NYSE: CANO-WT)
MD vs CANO-WT Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, MD's ROE is +0.20%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, MD is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for MD.Check CANO-WT's competition here
P3 Health Partners Inc. (NASDAQ: PIIIW)
MD vs PIIIW Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, PIIIW has a market cap of 16.1M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas PIIIW's P/E ratio is N/A. In terms of profitability, MD's ROE is +0.20%, compared to PIIIW's ROE of +1.61%. Regarding short-term risk, MD is less volatile compared to PIIIW. This indicates lower risk in terms of short-term price fluctuations for MD.Check PIIIW's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
MD vs AIH Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas AIH's P/E ratio is -2.78. In terms of profitability, MD's ROE is +0.20%, compared to AIH's ROE of +1.16%. Regarding short-term risk, MD is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for MD.Check AIH's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
MD vs PIII Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, PIII has a market cap of 14M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while PIII trades at $4.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas PIII's P/E ratio is -0.13. In terms of profitability, MD's ROE is +0.20%, compared to PIII's ROE of +1.61%. Regarding short-term risk, MD is less volatile compared to PIII. This indicates lower risk in terms of short-term price fluctuations for MD.Check PIII's competition here
Cano Health, Inc. (NYSE: CANO)
MD vs CANO Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas CANO's P/E ratio is -0.01. In terms of profitability, MD's ROE is +0.20%, compared to CANO's ROE of -1.49%. Regarding short-term risk, MD is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for MD.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
MD vs FPCG Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas FPCG's P/E ratio is 0.09. In terms of profitability, MD's ROE is +0.20%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, MD is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for MD.Check FPCG's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
MD vs FTRP Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas FTRP's P/E ratio is -1.22. In terms of profitability, MD's ROE is +0.20%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, MD is less volatile compared to FTRP. This indicates lower risk in terms of short-term price fluctuations for MD.Check FTRP's competition here
American Shared Hospital Services (AMEX: AMS)
MD vs AMS Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, AMS has a market cap of 8.2M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while AMS trades at $1.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas AMS's P/E ratio is -4.87. In terms of profitability, MD's ROE is +0.20%, compared to AMS's ROE of -0.07%. Regarding short-term risk, MD is less volatile compared to AMS. This indicates lower risk in terms of short-term price fluctuations for MD.Check AMS's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
MD vs BMGL Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, BMGL has a market cap of 6.2M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while BMGL trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas BMGL's P/E ratio is -0.79. In terms of profitability, MD's ROE is +0.20%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, MD is less volatile compared to BMGL. This indicates lower risk in terms of short-term price fluctuations for MD.Check BMGL's competition here
ModivCare Inc. (NASDAQ: MODV)
MD vs MODV Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas MODV's P/E ratio is -0.06. In terms of profitability, MD's ROE is +0.20%, compared to MODV's ROE of +0.88%. Regarding short-term risk, MD is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for MD.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
MD vs GBNH Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas GBNH's P/E ratio is -0.06. In terms of profitability, MD's ROE is +0.20%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, MD is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for MD.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE)
MD vs RHE Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas RHE's P/E ratio is -1.79. In terms of profitability, MD's ROE is +0.20%, compared to RHE's ROE of -1.31%. Regarding short-term risk, MD is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for MD.Check RHE's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
MD vs RHE-PA Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, MD's ROE is +0.20%, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, MD is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for MD.Check RHE-PA's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
MD vs TOIIW Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, MD's ROE is +0.20%, compared to TOIIW's ROE of +2.10%. Regarding short-term risk, MD is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for MD.Check TOIIW's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
MD vs AIDX Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, AIDX has a market cap of 3.3M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while AIDX trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas AIDX's P/E ratio is -0.36. In terms of profitability, MD's ROE is +0.20%, compared to AIDX's ROE of -3.87%. Regarding short-term risk, MD is less volatile compared to AIDX. This indicates lower risk in terms of short-term price fluctuations for MD.Check AIDX's competition here
Starling Oncology Inc. Wt (NASDAQ: STLNW)
MD vs STLNW Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, STLNW has a market cap of 2.4M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while STLNW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas STLNW's P/E ratio is -0.08. In terms of profitability, MD's ROE is +0.20%, compared to STLNW's ROE of +2.10%. Regarding short-term risk, MD is less volatile compared to STLNW. This indicates lower risk in terms of short-term price fluctuations for MD.Check STLNW's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
MD vs IMACW Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas IMACW's P/E ratio is N/A. In terms of profitability, MD's ROE is +0.20%, compared to IMACW's ROE of +0.46%. Regarding short-term risk, MD is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for MD.Check IMACW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
MD vs EUDAW Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, EUDAW has a market cap of 971.7K. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while EUDAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas EUDAW's P/E ratio is -0.02. In terms of profitability, MD's ROE is +0.20%, compared to EUDAW's ROE of -5.06%. Regarding short-term risk, MD is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for MD.Check EUDAW's competition here
Endovia Health Sciences, Inc. (AMEX: EDVA)
MD vs EDVA Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, EDVA has a market cap of 915.7K. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while EDVA trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas EDVA's P/E ratio is -0.01. In terms of profitability, MD's ROE is +0.20%, compared to EDVA's ROE of N/A. Regarding short-term risk, MD is less volatile compared to EDVA. This indicates lower risk in terms of short-term price fluctuations for MD.Check EDVA's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
MD vs CCM Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, CCM has a market cap of 518.1K. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while CCM trades at $3.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas CCM's P/E ratio is -1.20. In terms of profitability, MD's ROE is +0.20%, compared to CCM's ROE of +0.05%. Regarding short-term risk, MD is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for MD.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
MD vs NIVFW Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, NIVFW has a market cap of 35K. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas NIVFW's P/E ratio is N/A. In terms of profitability, MD's ROE is +0.20%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, MD is more volatile compared to NIVFW. This indicates higher risk in terms of short-term price fluctuations for MD.Check NIVFW's competition here
Talkspace, Inc. (NASDAQ: TALKW)
MD vs TALKW Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas TALKW's P/E ratio is 0.00. In terms of profitability, MD's ROE is +0.20%, compared to TALKW's ROE of +0.00%. Regarding short-term risk, MD is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for MD.Check TALKW's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
MD vs MNDR Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, MNDR has a market cap of 22.6K. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while MNDR trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas MNDR's P/E ratio is -0.06. In terms of profitability, MD's ROE is +0.20%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, MD is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for MD.Check MNDR's competition here
Tenon Medical, Inc. (NASDAQ: TNONW)
MD vs TNONW Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, TNONW has a market cap of 5.6K. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while TNONW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas TNONW's P/E ratio is N/A. In terms of profitability, MD's ROE is +0.20%, compared to TNONW's ROE of N/A. Regarding short-term risk, MD is more volatile compared to TNONW. This indicates higher risk in terms of short-term price fluctuations for MD.Check TNONW's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
MD vs NIVF Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, NIVF has a market cap of 4.3K. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while NIVF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas NIVF's P/E ratio is 0.13. In terms of profitability, MD's ROE is +0.20%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, MD is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for MD.Check NIVF's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
MD vs TVTY Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, TVTY has a market cap of 0. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas TVTY's P/E ratio is 19.06. In terms of profitability, MD's ROE is +0.20%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, MD is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for MD.Check TVTY's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
MD vs SLHGP Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, MD's ROE is +0.20%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, MD is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for MD.Check SLHGP's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
MD vs ATIP-WT Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, MD's ROE is +0.20%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, MD is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for MD.Check ATIP-WT's competition here
Kindred Healthcare, Inc. (NYSE: KND)
MD vs KND Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, KND has a market cap of 0. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas KND's P/E ratio is -1.14. In terms of profitability, MD's ROE is +0.20%, compared to KND's ROE of -0.53%. Regarding short-term risk, MD is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for MD.Check KND's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
MD vs SLHG Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, SLHG has a market cap of 0. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas SLHG's P/E ratio is -1.48. In terms of profitability, MD's ROE is +0.20%, compared to SLHG's ROE of N/A. Regarding short-term risk, MD is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for MD.Check SLHG's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
MD vs TLMDW Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas TLMDW's P/E ratio is N/A. In terms of profitability, MD's ROE is +0.20%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, MD is less volatile compared to TLMDW. This indicates lower risk in terms of short-term price fluctuations for MD.Check TLMDW's competition here
DocGo Inc. (NASDAQ: DCGOW)
MD vs DCGOW Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas DCGOW's P/E ratio is N/A. In terms of profitability, MD's ROE is +0.20%, compared to DCGOW's ROE of -1.16%. Regarding short-term risk, MD is less volatile compared to DCGOW. This indicates lower risk in terms of short-term price fluctuations for MD.Check DCGOW's competition here
Hanger, Inc. (NYSE: HNGR)
MD vs HNGR Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, HNGR has a market cap of 0. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas HNGR's P/E ratio is 19.71. In terms of profitability, MD's ROE is +0.20%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, MD is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for MD.Check HNGR's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
MD vs DVCR Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, DVCR has a market cap of 0. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas DVCR's P/E ratio is 28.34. In terms of profitability, MD's ROE is +0.20%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, MD is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for MD.Check DVCR's competition here
Almost Family Inc. (NASDAQ: AFAM)
MD vs AFAM Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, AFAM has a market cap of 0. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas AFAM's P/E ratio is N/A. In terms of profitability, MD's ROE is +0.20%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, MD is less volatile compared to AFAM. This indicates lower risk in terms of short-term price fluctuations for MD.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
MD vs TLMD Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, TLMD has a market cap of 0. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas TLMD's P/E ratio is -1.60. In terms of profitability, MD's ROE is +0.20%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, MD is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for MD.Check TLMD's competition here
New Frontier Health Corporation (NYSE: NFH)
MD vs NFH Comparison October 2026
Pediatrix Medical Group, Inc. (NYSE: MD) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MD stands at 2.2B. In comparison, NFH has a market cap of 0. Regarding current trading prices, MD is priced at $27.38 on the NYSE, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MD currently has a P/E ratio of 12.21, whereas NFH's P/E ratio is -19.75. In terms of profitability, MD's ROE is +0.20%, compared to NFH's ROE of -0.06%. Regarding short-term risk, MD is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for MD.Check NFH's competition here